Iambic Named to CNBC’s 2025 Disruptor 50 List
Iambic Therapeutics, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, announced today that it has been...
Tag : CNBC Disruptor 50
Rad AI Named to CNBC Disruptor 50 For Pioneering GenAI in Healthcare
Recognition comes amid rapid growth, with Rad AI recently securing $68 million in Series C Funding and ranking 19th on the Deloitte Fast 500. Rad AI, the...